Literature DB >> 22459734

Dried blood spot analysis combined with limited sampling models can advance therapeutic drug monitoring of tuberculosis drugs.

Jan-Willem C Alffenaar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22459734     DOI： 10.1093/infdis/jis270

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

1.  Strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response.

Authors:  Onno W Akkerman; Richard van Altena; Mathieu S Bolhuis; Tjip S van der Werf; Jan-Willem Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2014       Impact factor: 5.191

2.  A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs.

Authors:  Alper Daskapan; Lusiana R Idrus; Maarten J Postma; Bob Wilffert; Jos G W Kosterink; Ymkje Stienstra; Daniel J Touw; Aase B Andersen; Adrie Bekker; Paolo Denti; Agibothu K Hemanth Kumar; Kidola Jeremiah; Awewura Kwara; Helen McIlleron; Graeme Meintjes; Joep J van Oosterhout; Geetha Ramachandran; Neesha Rockwood; Robert J Wilkinson; Tjip S van der Werf; Jan-Willem C Alffenaar
Journal:  Clin Pharmacokinet       Date:  2019-06       Impact factor: 6.447

3.  Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis.

Authors:  Roy Gerona; Anita Wen; Aaron T Chin; Catherine A Koss; Peter Bacchetti; John Metcalfe; Monica Gandhi
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

4.  Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis.

Authors:  Vidya Mave; Aarti Kinikar; Anju Kagal; Smita Nimkar; Hari Koli; Sultanat Khwaja; Renu Bharadwaj; Roy Gerona; Anita Wen; Geetha Ramachandran; Hemanth Kumar; Peter Bacchetti; Kelly E Dooley; Nikhil Gupte; Amita Gupta; Monica Gandhi
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.